- Home
- AMBO vs AEON Comparison
AMBO vs AEON Comparison
Compare AMBO & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBO
- AEON
- Stock Information
- Founded
- AMBO 2000
- AEON N/A
- Country
- AMBO United States
- AEON United States
- Employees
- AMBO N/A
- AEON N/A
- Industry
- AMBO Other Consumer Services
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- AMBO Real Estate
- AEON Health Care
- Exchange
- AMBO Nasdaq
- AEON Nasdaq
- Market Cap
- AMBO 12.7M
- AEON 13.5M
- IPO Year
- AMBO 2010
- AEON N/A
- Fundamental
- Price
- AMBO $3.49
- AEON $0.91
- Analyst Decision
- AMBO
- AEON Strong Buy
- Analyst Count
- AMBO 0
- AEON 1
- Target Price
- AMBO N/A
- AEON $7.20
- AVG Volume (30 Days)
- AMBO 51.8K
- AEON 312.8K
- Earning Date
- AMBO 08-05-2025
- AEON 11-12-2025
- Dividend Yield
- AMBO N/A
- AEON N/A
- EPS Growth
- AMBO N/A
- AEON N/A
- EPS
- AMBO 0.69
- AEON N/A
- Revenue
- AMBO $9,699,000.00
- AEON N/A
- Revenue This Year
- AMBO N/A
- AEON N/A
- Revenue Next Year
- AMBO N/A
- AEON N/A
- P/E Ratio
- AMBO $5.55
- AEON N/A
- Revenue Growth
- AMBO 23.73
- AEON N/A
- 52 Week Low
- AMBO $1.25
- AEON $0.38
- 52 Week High
- AMBO $6.75
- AEON $64.80
- Technical
- Relative Strength Index (RSI)
- AMBO 42.19
- AEON 47.73
- Support Level
- AMBO $3.40
- AEON $0.83
- Resistance Level
- AMBO $4.44
- AEON $1.09
- Average True Range (ATR)
- AMBO 0.46
- AEON 0.10
- MACD
- AMBO -0.11
- AEON -0.01
- Stochastic Oscillator
- AMBO 6.16
- AEON 18.19
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.